Dilated cardiomyopathy (DCM) is a serious heart disease in dogs in which the heart muscle weakens and enlarges, leading to reduced cardiac output, congestive heart failure, and significantly shortened lifespan in affected individuals.
DCM imposes significant welfare burdens through progressive cardiac insufficiency, exercise limitation, and the risk of sudden death or respiratory distress from congestive heart failure. Dogs in congestive heart failure experience dyspnoea — distressing difficulty breathing — that requires prompt medical management. Screening programmes for Dobermans using echocardiography and Holter monitoring allow intervention in the occult phase, before heart failure develops, which extends life and welfare. Owner education about early signs — increased resting respiratory rate, reduced exercise tolerance — enables timely veterinary assessment. End-of-life decisions require careful quality-of-life assessment when cardiac function deteriorates despite maximal treatment.